​

Funding Round

Corporate Round - Ionpath

Corporate Round - Ionpath

Investment Firm

Overview

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

Announced Date

May 11, 2022

Funding Type

Corporate Round

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Thermo Fisher Scientific

Thermo Fisher Scientific

No designation

Participant Investors

1

Investor Name
Participant InvestorThermo Fisher Scientific

Round Details and Background

Ionpath raised an undisclosed amount on 2022-05-11 in Corporate Round

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 20, 2018
Series A - Ionpath
1-undefined
Oct 01, 2015
Seed Round - Ionpath
1-undefined
Sep 24, 2020
Series B - Ionpath
9-18.0M
May 11, 2022
Corporate Round - Ionpath
1-undefined

Recent Activity

There is no recent news or activity for this profile.